Nippon Shinyaku Files Acamprosate NDA In Japan
This article was originally published in PharmAsia News
Executive Summary
Nippon Shinyaku submitted its new drug approval application for acamprosate with Japan’s Ministry of Health, Labor and Welfare for alcohol dependence.